C-GLYCOSIDES FROM HEXA-O-ACETYL-D-LACTAL

DOI: 10.1007/BF01172291

Source and publish data:

Bulletin of the Academy of Sciences of the USSR Division of Chemical Science p. 1726 (1991)

Update date:2022-08-03

Topics:

Authors:

Tolstikov, A. G.

Prokopenko, O. F.

Spirikhin, L. V.

Sultanmuratova, V. R.

Berg, A. A.

Tolstikov, G. A.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1007/BF01172291

Full text of DOI:10.1007/BF01172291

Products guided by the article

Product name:Acetic acid (3R,4S,5S,6R)-4,5-diacetoxy-6-acetoxymethyl-2-[(2R,3S,6S)-2-acetoxymethyl-6-(2-oxo-2-phenyl-ethyl)-3,6-dihydro-2H-pyran-3-yloxy]-tetrahydro-pyran-3-yl ester

Cas No:137687-05-9

R&D Labs maybe for 137687-05-9

Huangshan Violet Biological Technology Co., Ltd

Contact:+86-559-2335676

Address:16-201 JinShanYuan,JiangNan New City,TunXi District,HuangShan City,AnHui Province,China
Hubei Xinghuo Chemical Co., Ltd.,

Contact:13925817279 13907299441

Address:Xinghuo Fine Chemistry Industrial Park, Xiaochang County, Hubei Province, China
HaiNan Periwinkle Pharmaceutical Co.,Ltd.

website:http://www.cchpharm.com/en/index.html

Contact:020-82208978

Address:Gongye road,Wuzhishan city,HaiNan province
Zhuhai Jiacheng Biological Technology Co., Ltd

Contact:0756-8800233

Address:room 222, Lianhua road , Gongbei ,Zhuhai, Guangdong ,China
Shijiazhuang Haotian Chemical Co., Ltd.

Contact:86-311-85044374

Address:293 Donggang Road

Relevant to this article

Excited Precursor Reactivity, Fast 1,2-H Shifts, and Diffusion-Controlled Methanol Insertion in 1,2-Diphenylalkylidenes

Doi:10.1021/jo990172i
(1999)
Synthesis and evaluation for biological activity of 3-alkyl and 3-halogenoalkyl-quinoxalin-2-ones variously substituted. Part 4

Doi:10.1016/S0014-827X(01)01153-3
(2002)
Discovery of N-substituted 3-arylisoquinolone derivatives as antitumor agents originating from O-substituted 3-arylisoquinolines via [2,3] or [3,3] rearrangement

Doi:10.1016/j.ejmech.2014.03.008
(2014)
Discovery of a potent and highly selective transforming growth factor β receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD)

Doi:10.1016/j.bmc.2016.07.006
(2016)
Structural development of liver X receptor (LXR) antagonists derived from thalidomide-related glucosidase inhibitors

Doi:10.1248/cpb.55.1750
(2007)
Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin 1 and 3 receptors contributing to the insurmountable mode of antagonism by dual NK₁/NK₃ antagonists

Doi:10.1021/jm2017072
(2012)

Article Doi